Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search

Thrombosis risk factors

Citations 81-90 of 165 total displayed.

Past content (since Dec 2000):

Articles
Stent Thrombosis After Successful Sirolimus-Eluting Stent Implantation
Allen Jeremias, Brett Sylvia, Jonathan Bridges, Ajay J. Kirtane, Brian Bigelow, Duane S. Pinto, Kalon K.L. Ho, David J. Cohen, Lawrence A. Garcia, Donald E. Cutlip, and Joseph P. Carrozza, Jr
Circulation published April 12, 2004, doi:10.1161/01.CIR.0000127105.99982.21 [Abstract]  

Articles
Clinical Usefulness of Very High and Very Low Levels of C-Reactive Protein Across the Full Range of Framingham Risk Scores
Paul M Ridker and Nancy Cook
Circulation published March 29, 2004, doi:10.1161/01.CIR.0000125690.80303.A8 [Abstract]  

Clinical Investigations and Reports
Endothelial Cell Markers and the Risk of Coronary Heart Disease: The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study
P.E. Morange, C. Simon, M.C. Alessi, G. Luc, D. Arveiler, J. Ferrieres, P. Amouyel, A. Evans, P. Ducimetiere, I. Juhan-Vague on behalf of the PRIME Study Group
Circulation 2004;109:1343-1348; published online before print as doi:10.1161/01.CIR.0000120705.55512.EC [Abstract] [Full text]  

Basic Science Reports
Ultrafine Particles Exert Prothrombotic but Not Inflammatory Effects on the Hepatic Microcirculation in Healthy Mice In Vivo
Andrej Khandoga, Andreas Stampfl, Shinji Takenaka, Holger Schulz, Roman Radykewicz, Wolfgang Kreyling, and Fritz Krombach
Circulation 2004;109:1320-1325; published online before print as doi:10.1161/01.CIR.0000118524.62298.E8 [Abstract] [Full text]  

Articles
Endothelial Cell Markers and the Risk of Coronary Heart Disease. The Prospective Epidemiological Study of Myocardial Infarction (PRIME) Study
P. E. Morange, C. Simon, M. C. Alessi, G. Luc, D. Arveiler, J. Ferrieres, P. Amouyel, A. Evans, P. Ducimetiere, I. Juhan-Vague on behalf of the PRIME Study Group
Circulation published March 15, 2004, doi:10.1161/01.CIR.0000120705.55512.EC [Abstract]  

Articles
Ultrafine Particles Exert Prothrombotic but Not Inflammatory Effects on the Hepatic Microcirculation in Healthy Mice In Vivo
Andrej Khandoga, Andreas Stampfl, Shinji Takenaka, Holger Schulz, Roman Radykewicz, Wolfgang Kreyling, and Fritz Krombach
Circulation published March 8, 2004, doi:10.1161/01.CIR.0000118524.62298.E8 [Abstract]  

Special Reports
Cardiovascular Consequences of Sleep-Disordered Breathing: Past, Present and Future: Report of a Workshop From the National Center on Sleep Disorders Research and the National Heart, Lung, and Blood Institute
Stuart F. Quan and Bernard J. Gersh
Circulation 2004;109:951-957, doi:10.1161/01.CIR.0000118216.84358.22 [Full text]  

Clinical Investigations and Reports
Differences Between Mainstream and Sidestream Cigarette Smoke Extracts and Nicotine in the Activation of Platelets Under Static and Flow Conditions
David Rubenstein, Jolyon Jesty, and Danny Bluestein
Circulation 2004;109:78-83; published online before print as doi:10.1161/01.CIR.0000108395.12766.25 [Abstract] [Full text]  

Clinical Investigations and Reports
Angiotensin-Converting Enzyme Inhibition Alters the Fibrinolytic Response to Cardiopulmonary Bypass
Mias Pretorius, Laine J. Murphey, Julie A. McFarlane, Douglas E. Vaughan, and Nancy J. Brown
Circulation 2003;108:3079-3083; published online before print as doi:10.1161/01.CIR.0000105765.54573.60 [Abstract] [Full text]  

Articles
Differences Between Mainstream and Sidestream Cigarette Smoke Extracts and Nicotine in the Activation of Platelets Under Static and Flow Conditions
David Rubenstein, Jolyon Jesty, and Danny Bluestein
Circulation published December 22, 2003, doi:10.1161/01.CIR.0000108395.12766.25 [Abstract]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

* Subspecialty Collections Home

* Show  Thrombosis risk factors
 collections from other journals.

* Related collections:
 Thrombosis
 Anticoagulant mechanisms
 Anticoagulants
 Arterial thrombosis
 Coagulation and fibronolysis
 Coagulation inhibitors
 Coagulation
 Deep vein thrombosis
 Fibrinogen/fibrin
 Fibrinolysis
 Platelet adhesion
 Platelet function inhibitors
 Platelets
 Thrombin
 Thrombophilia
 Thrombosis risk factors